SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-000272
Filing Date
2020-01-03
Accepted
2020-01-03 21:41:04
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7710
  Complete submission text file 0001179110-20-000272.txt   9057
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 20507947

Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences